EC5026 oral tablet: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Phase breakdown

Conditions being studied

Recruiting trials involving EC5026 oral tablet

• Renal Impairment Study for Oral EC5026
  NCT07694544 · Phase: Phase 1 · Ages: 55 Years and older · Sex: All (male and female) · 1 location
• Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study)
  NCT07142044 · Phase: Phase 1, Phase 2 · Ages: 50 Years to 80 Years · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve EC5026 oral tablet?

2 recruiting trials across 3 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.